FMD and SCAD registry study in Europe and beyond
Part of Heart & circulation clinical trials.
This trial is a registry, meaning it collects detailed medical information to better understand fibromuscular dysplasia (FMD) and a specific type of heart-vessel dissection (SCAD) linked to FMD. It may help researchers learn who is at risk and guide better care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of FMD (either “string-of-beads” in multiple spots or a single focal narrowing)
- Or you have SCAD and scans found FMD “string-of-beads” in blood vessels outside the heart
- Or you have “atypical FMD”/FMD-like findings (dissection or multiple artery enlargements before age 60) without the typical “string-of-beads” pattern
- Your FMD/related diagnosis cannot be based on ultrasound alone—you must have confirmatory imaging (CT angiography, MRI angiography, or a catheter angiogram)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with fibromuscular dysplasia (FMD) and related conditions to learn what causes them and how they behave over time. You may also be able to join if you are a healthy person matched by age and gender to help compare results.
This study looks at people admitted with a recent heart event (STEMI, NSTEMI, or unstable angina) and who were found to have SCAD on a heart scan. It may help doctors better understand and manage SCAD after these urgent events.
This study tests whether a supervised exercise program is safe and helpful for people who have had a spontaneous tear in a heart artery (SCAD) or fibromuscular dysplasia (a condition affecting blood vessel walls). The goal is to see if exercise can improve heart health after recovery from these conditions.
This study follows people with FSHD2 over 18 months to learn how the disease progresses and affects daily life. No new drugs are tested—just regular check-ups and an MRI scan.
This study is a registry that collects medical information from people with nephrotic syndrome caused by FSGS or minimal change disease (MCD). It may help doctors better understand these conditions and improve future care, especially by tracking patients over time.
This registry collects information from people diagnosed with kidney artery fibromuscular dysplasia (or certain similar, “atypical” cases). It helps doctors better understand patterns of the condition and may guide future research and care.
Hear when a new Fibromuscular Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.